Skip to main content
Top
Published in: Acta Neuropathologica 3/2011

01-03-2011 | Case Report

New neuropathological findings in Unverricht–Lundborg disease: neuronal intranuclear and cytoplasmic inclusions

Authors: Nicola R. Cohen, Simon R. Hammans, James Macpherson, James A. R. Nicoll

Published in: Acta Neuropathologica | Issue 3/2011

Login to get access

Abstract

Unverricht–Lundborg disease (EPM1A), also known as Baltic myoclonus, is the most common form of progressive myoclonic epilepsy. It is inherited as an autosomal recessive trait, due to mutations in the Cystatin-B gene promoter region. Although there is much work on rodent models of this disease, there is very little published neuropathology in patients with EPM1A. Here, we present the neuropathology of a patient with genetically confirmed EPM1A, who died at the age of 76. There was atrophy and gliosis affecting predominantly the cerebellum, frontotemporal cortex, hippocampus and thalamus. We have identified neuronal cytoplasmic inclusions containing the lysosomal proteins, Cathepsin-B and CD68. These inclusions also showed immunopositivity to both TDP-43 and FUS, in some cases associated with an absence of normal neuronal nuclear TDP-43 staining. There were also occasional ubiquitinylated neuronal intranuclear inclusions, some of which were FUS immunopositive. This finding is consistent with neurodegeneration in EPM1A as at least a partial consequence of lysosomal damage to neurons, which have reduced Cystatin-B-related neuroprotection. It also reveals a genetically defined neurodegenerative disease with both FUS and TDP-43 related pathology.
Literature
1.
go back to reference Alakurtti K, Weber E, Rinne R et al (2005) Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations. Eur J Hum Genet 13:208–215CrossRefPubMed Alakurtti K, Weber E, Rinne R et al (2005) Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations. Eur J Hum Genet 13:208–215CrossRefPubMed
2.
go back to reference Bräanvall K, Hjelm H, Korhonen L, Lahtinen U, Lehesjoki A-E, Lindholm D (2003) Cystatin-B is expressed by neural stem cells and by differentiated neurons and astrocytes. Biochem Biophys Res Commun 308:369–374CrossRef Bräanvall K, Hjelm H, Korhonen L, Lahtinen U, Lehesjoki A-E, Lindholm D (2003) Cystatin-B is expressed by neural stem cells and by differentiated neurons and astrocytes. Biochem Biophys Res Commun 308:369–374CrossRef
3.
go back to reference Chew NK, Mir P, Edwards MJ et al (2008) The natural history of Unverricht–Lundborg disease: a report of eight genetically proven cases. Mov Disord 23:107–113CrossRefPubMed Chew NK, Mir P, Edwards MJ et al (2008) The natural history of Unverricht–Lundborg disease: a report of eight genetically proven cases. Mov Disord 23:107–113CrossRefPubMed
4.
go back to reference Danner N, Julkunen P, Khyuppenen J et al (2009) Altered cortical inhibition in Unverricht–Lundborg type progressive myoclonus epilepsy (EPM1). Epilepsy Res 85:81–88CrossRefPubMed Danner N, Julkunen P, Khyuppenen J et al (2009) Altered cortical inhibition in Unverricht–Lundborg type progressive myoclonus epilepsy (EPM1). Epilepsy Res 85:81–88CrossRefPubMed
5.
go back to reference Doi H, Okamura K, Bauer PO et al (2008) RNA binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells. J Biol Chem 283:6489–6500CrossRefPubMed Doi H, Okamura K, Bauer PO et al (2008) RNA binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells. J Biol Chem 283:6489–6500CrossRefPubMed
6.
go back to reference Eldridge R, Iivanainen M, Stern R, Koerber T, Wilder BJ (1983) “Baltic” myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 2:838–842CrossRefPubMed Eldridge R, Iivanainen M, Stern R, Koerber T, Wilder BJ (1983) “Baltic” myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 2:838–842CrossRefPubMed
7.
go back to reference Fujii R, Okabe S, Urushido T et al (2005) The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol 15:587–593CrossRefPubMed Fujii R, Okabe S, Urushido T et al (2005) The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol 15:587–593CrossRefPubMed
8.
go back to reference Haltia M, Kristensson K, Sourander P (1969) Neuropathological studies in three Scandinavian cases of progressive myoclonus epilepsy. Acta Neurol Scand 45:63–77CrossRefPubMed Haltia M, Kristensson K, Sourander P (1969) Neuropathological studies in three Scandinavian cases of progressive myoclonus epilepsy. Acta Neurol Scand 45:63–77CrossRefPubMed
9.
go back to reference Kirkin V, McEwan DG, Novak I, Dikic I (2009) A role for ubiquitin in selective autophagy. Mol Cell 34:259–269CrossRefPubMed Kirkin V, McEwan DG, Novak I, Dikic I (2009) A role for ubiquitin in selective autophagy. Mol Cell 34:259–269CrossRefPubMed
10.
go back to reference Korja M, Kaasinen V, Lamusuo S, Parkkola R, Nagren K, Marttila RJ (2007) Substantial thalamostriatal dopaminergic defect in Unverricht–Lundborg disease. Epilepsia 48:1768–1773CrossRefPubMed Korja M, Kaasinen V, Lamusuo S, Parkkola R, Nagren K, Marttila RJ (2007) Substantial thalamostriatal dopaminergic defect in Unverricht–Lundborg disease. Epilepsia 48:1768–1773CrossRefPubMed
11.
go back to reference Koskenkorva P, Khyuppenen J, Niskanen E et al (2009) Motor cortex and thalamic atrophy in Unverricht–Lundborg disease: voxel-based morphometric study. Neurology 73:606–611CrossRefPubMed Koskenkorva P, Khyuppenen J, Niskanen E et al (2009) Motor cortex and thalamic atrophy in Unverricht–Lundborg disease: voxel-based morphometric study. Neurology 73:606–611CrossRefPubMed
12.
go back to reference Koskiniemi M, Donner M, Majuri H, Haltia M, Norio R (1974) Progressive myoclonus epilepsy: a clinical and histopathological study. Acta Neurol Scand 50:307–332CrossRefPubMed Koskiniemi M, Donner M, Majuri H, Haltia M, Norio R (1974) Progressive myoclonus epilepsy: a clinical and histopathological study. Acta Neurol Scand 50:307–332CrossRefPubMed
13.
go back to reference Kwiatkowski TJ Jr, Bosco DA, Leclerc AL et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205–1208CrossRefPubMed Kwiatkowski TJ Jr, Bosco DA, Leclerc AL et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205–1208CrossRefPubMed
14.
15.
go back to reference Lehesjoki AE, Koskiniemi M (1998) Clinical features and genetics of progressive myoclonus epilepsy of the Unverricht–Lundborg type. Ann Med 30:474–480CrossRefPubMed Lehesjoki AE, Koskiniemi M (1998) Clinical features and genetics of progressive myoclonus epilepsy of the Unverricht–Lundborg type. Ann Med 30:474–480CrossRefPubMed
16.
go back to reference MacKenzie IRA, Neumann M, Bigio EH et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119:1–4CrossRefPubMed MacKenzie IRA, Neumann M, Bigio EH et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119:1–4CrossRefPubMed
17.
go back to reference Mackenzie IR, Foti D, Woulfe J, Hurwitz TA (2008) Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain 131:1282–1293CrossRefPubMed Mackenzie IR, Foti D, Woulfe J, Hurwitz TA (2008) Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain 131:1282–1293CrossRefPubMed
18.
go back to reference Mascalchi M, Michelucci R, Cosottini M et al (2002) Brainstem involvement in Unverricht–Lundborg disease (EPM1): an MRI and (1)H MRS study. Neurology 58:1686–1689PubMed Mascalchi M, Michelucci R, Cosottini M et al (2002) Brainstem involvement in Unverricht–Lundborg disease (EPM1): an MRI and (1)H MRS study. Neurology 58:1686–1689PubMed
19.
go back to reference Munoz DG, Neumann M, Kusaka H et al (2009) FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118:617–627CrossRefPubMed Munoz DG, Neumann M, Kusaka H et al (2009) FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118:617–627CrossRefPubMed
20.
go back to reference Neumann M, Roeber S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IR (2009) Abundant FUS immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol 118:605–616CrossRefPubMed Neumann M, Roeber S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IR (2009) Abundant FUS immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol 118:605–616CrossRefPubMed
21.
go back to reference Neumann M, Sampathu DM, Kwong LK (2006) Ubiquitinylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133CrossRefPubMed Neumann M, Sampathu DM, Kwong LK (2006) Ubiquitinylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133CrossRefPubMed
22.
go back to reference Pennacchio L, Lehesjoki A-E, Stone NE et al (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271:1731–1734CrossRefPubMed Pennacchio L, Lehesjoki A-E, Stone NE et al (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271:1731–1734CrossRefPubMed
23.
go back to reference Riccio M, Santi S, Dembic M et al (2005) Cell-specific expression of the epm1 (cystatin B) gene in developing rat cerebellum. Neurobiol Dis 20:104–114CrossRefPubMed Riccio M, Santi S, Dembic M et al (2005) Cell-specific expression of the epm1 (cystatin B) gene in developing rat cerebellum. Neurobiol Dis 20:104–114CrossRefPubMed
24.
go back to reference Urwin H, Josephs KA, Rohrer JD et al (2010) FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol 120:33–41CrossRefPubMed Urwin H, Josephs KA, Rohrer JD et al (2010) FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol 120:33–41CrossRefPubMed
25.
go back to reference Vance C, Rogelj B, Hortobagyi T et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208–1211CrossRefPubMed Vance C, Rogelj B, Hortobagyi T et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208–1211CrossRefPubMed
26.
go back to reference Virtaneva K, D’Amato E, Miao J et al (1997) Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 15:393–396CrossRefPubMed Virtaneva K, D’Amato E, Miao J et al (1997) Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 15:393–396CrossRefPubMed
27.
go back to reference Zinszner H, Sok J, Immanuel D, Yin Y, Ron D (1997) TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 110:1741–1750PubMed Zinszner H, Sok J, Immanuel D, Yin Y, Ron D (1997) TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 110:1741–1750PubMed
Metadata
Title
New neuropathological findings in Unverricht–Lundborg disease: neuronal intranuclear and cytoplasmic inclusions
Authors
Nicola R. Cohen
Simon R. Hammans
James Macpherson
James A. R. Nicoll
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 3/2011
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-010-0738-2

Other articles of this Issue 3/2011

Acta Neuropathologica 3/2011 Go to the issue